中华医学图书情报杂志2017，Vol.26Issue(6)：36-40,5.DOI:10.3969/j.issn.1671-3982.2017.06.009
我国药品强制许可制度存在的问题及对策
Problems in China pharmaceutical compulsory licensing system and their solutions
高迪 1谢靖凡 2韩娟娟 3柴慧婷 3顾金辉3
作者信息
- 1. 中国医学科学院病原生物学研究所,北京 100730
- 2. 厦门大学科技处,福建 厦门 361005
- 3. 国家卫生和计划生育委员会,北京 100044
- 折叠
摘要
Abstract
The Doha Declaration has entrusted to the members of WHO the right to use the compulsory licensing for drug patents in the face of global public health crises.Although the basic compulsory licensing system for drug patents has been established in China, the efficiency of its implementation is low, the responsibility of its executive departments is unclear, the related rules are not fully understood by pharmaceutical enterprises, it is thus necessary to improve and perfect the relevant legal provisions and systems in order to effectively improve the accessibility of drugs.关键词
专利法/强制许可/公共卫生健康Key words
Patent law/Compulsory licensing/Public health分类
医药卫生引用本文复制引用
高迪,谢靖凡,韩娟娟,柴慧婷,顾金辉..我国药品强制许可制度存在的问题及对策[J].中华医学图书情报杂志,2017,26(6):36-40,5.
